TherapeutAix will be at the ERS Congress 2024 taking place in Vienna, Austria from 7-11th September.
The Congress, hosted at RX Messe Wien, will bring together the world’s respiratory experts to showcase the latest advances in respiratory medicine and science.
The theme of this year’s Congress is ‘Humans and machines: getting the balance right’ and focus on developments in AI in the respiratory field.
Simon Cruwys and Bob Humphries will be heading to Vienna and look forward to hearing the latest news and developments in the world of respiratory, as well as catching up with friends and colleagues.
TherapeutAix has been working closely with our partners at Fraunhofer ITEM and Nordic Bioscience to develop assays to support non-TGF pathway approaches to tackling lung fibrosis. We are delighted to see that one of our clients, Odin Therapeutics, has been selected to present some of this data as a Late Breaking Abstract. “Tankyrase inhibition demonstrates anti-fibrotic effects in vitro, ex vivo, and in vivo in preclinical pulmonary fibrosis models” will be presented in the ‘Clinical translation in rare interstitial lung diseases session’ on Tuesday 10th September between 8-9.30am.
If you would like to arrange a meeting at the Congress, please don’t hesitate to get in touch.
Find out more about the ERS Congress here.